GHK-Cu — Copper-Binding Tripeptide

📖 Wiki Page

therapeutic993 wordssynced 2026-04-02

GHK-Cu — Copper-Binding Tripeptide

<table class="infobox infobox-therapeutic">
<tr>
<th class="infobox-header" colspan="2">GHK-Cu — Copper-Binding Tripeptide</th>
</tr>
<tr>
<td class="label">Study</td>
<td>Model</td>
</tr>
<tr>
<td class="label">Pickart et al. (2015)</td>
<td>In vitro</td>
</tr>
<tr>
<td class="label">van Heemst et al. (2022)</td>
<td>Mouse AD model</td>
</tr>
<tr>
<td class="label">Campisi et al. (2019)</td>
<td>Mouse aging</td>
</tr>
<tr>
<td class="label">Route</td>
<td>Dose Range</td>
</tr>
<tr>
<td class="label">Topical</td>
<td>0.5-2% solution</td>
</tr>
<tr>
<td class="label">Subcutaneous</td>
<td>1-2 mg</td>
</tr>
<tr>
<td class="label">Intranasal (research)</td>
<td>0.5-1 mg</td>
</tr>
<tr>
<td class="label">Oral</td>
<td>2-5 mg</td>
</tr>
<tr>
<td class="label">Interaction</td>
<td>Effect</td>
</tr>
<tr>
<td class="label">Copper supplements</td>
<td>Potential copper overload</td>
</tr>
<tr>
<td class="label">Chelators (EDTA)</td>
<td>May reduce GHK-Cu efficacy</td>
</tr>
<tr>
<td class="label">Antioxidants</td>
<td>Potential synergy</td>
</tr>
</table>

Path: /therapeutics/ghk-cu Also Known As: Copper tripeptide, GHK-Cu, GHK-Copper Chemical Formula: C_14H_24N_6O_4Cu Sequence: Gly-Lys-Lys (with Cu²⁺ ion) Molecular Weight: ~403 Da (peptide), ~466 Da (with copper)

Overview

...

GHK-Cu — Copper-Binding Tripeptide

Overview

Mermaid diagram (expand to render)

GHK-Cu is a naturally occurring copper-binding tripeptide discovered in human plasma in 1973. It plays important roles in tissue repair, inflammation modulation, and cellular signaling. The peptide's ability to bind copper makes it a crucial factor in copper-dependent enzymatic processes.

Mechanism of Action

1. Copper Delivery and Enzymatic Cofactor

Copper transport: GHK delivers copper ions to cells in a regulated manner[@pickart2013]
Enzyme activation: Serves as cofactor for copper-dependent enzymes including:
Lysyl oxidase (cross-links collagen and elastin)[@rojkind1995]
Cu/Zn superoxide dismutase (antioxidant defense)[@fridovich1997]
Cytochrome c oxidase (mitochondrial energy)[@kadenbach2000]

2. Anti-Inflammatory Effects

Modulates cytokine expression: Reduces pro-inflammatory TNF-α, IL-6 while enhancing anti-inflammatory IL-10[@miller2018]
Inhibits NF-κB pathway: Prevents inflammatory gene transcription[@simpson2020]
Reduces oxidative stress: Enhances antioxidant enzyme expression[@luo2021]

3. Tissue Regeneration

Stimulates collagen synthesis: Increases collagen I and III production in fibroblasts[@maquart1990]
Promotes angiogenesis: Upregulates VEGF expression for blood vessel formation[@sivaraman2018]
Accelerates wound healing: Multiple mechanisms including fibroblast migration, keratinocyte proliferation[@pickart2016]

4. Anti-Aging and Cellular Senescence

Senolytic activity: May help clear senescent cells[@lee2019]
Telomere protection: Some evidence suggests telomere length preservation[@barcena2018]
Mitochondrial support: Improves mitochondrial function and reduces ROS[@campisi2019]

5. Potential Neuroprotective Mechanisms

While CNS research is emerging, several mechanisms suggest neuroprotective potential:

Copper homeostasis: Proper copper regulation is critical for neuronal function[@klis2021]
SOD activation: Cu/Zn SOD protects neurons from oxidative damage[@tainer1996]
Wound healing in CNS: May support repair processes in neural tissue[@hsu2022]
Neurotrophic effects: Some studies suggest NGF and BDNF modulation[@mochizuki2010]

Evidence in Neurodegenerative Disease

Preclinical Data

Clinical Evidence

Current status: Limited direct clinical trials in neurodegenerative disease. Most human data comes from:

Cosmetic and dermatological applications[@pickart2015a]
Wound healing studies[@ahmed2016]
Anti-aging research[@van2020]

Ongoing research: Several academic groups investigating GHK-Cu in AD/PD models, but no registered Phase 2/3 trials yet.

Dosing and Administration

Typical Dosing Protocols

Administration Considerations

Topical: Most common form; well-absorbed through skin
Subcutaneous: Better systemic availability
Intranasal: Potential direct CNS delivery (investigational)
Combination: Often used with BPC-157 for synergistic effects
Copper content: Each GHK-Cu molecule binds one Cu²⁺ ion (~16% copper by weight)

Safety Profile

Adverse Effects

Generally recognized as safe (GRAS) for topical use
Oral/subcutaneous: Limited data, but no significant toxicity in animal studies
Possible: Mild skin irritation (topical), transient redness

Contraindications

Wilson's disease (copper metabolism disorder)
Active copper allergy
Pregnancy/breastfeeding (insufficient data)

Drug Interactions

Relevance to CBS/PSP Patient

Potential Benefits

Anti-inflammatory: Systemic anti-inflammatory effects

Tissue healing: May support recovery from interventions

Antioxidant: Copper-dependent SOD activation protects neurons

Anti-aging: Addresses age-related decline in copper homeostasis

Wound care: Post-surgical (DBS) healing support

Case For

Excellent safety profile, especially topically
Multiple mechanisms complement other therapies
Addresses copper homeostasis (declines with age)
Easily accessible as topical/oral supplement
Synergistic with BPC-157

Case Against

No direct clinical evidence in tauopathies
Limited long-term human safety data for systemic use
Not FDA-approved for neurodegenerative indications
Quality varies by manufacturer

Net Assessment

Priority: Consider — Low-risk adjunct therapy with favorable safety profile. The antioxidant and anti-inflammatory mechanisms are relevant to tauopathy pathology. Recommend topical application as first approach (better safety data), with subcutaneous as option if tolerated. May provide modest benefits as part of comprehensive treatment approach.

Confidence: Low — Strong mechanistic rationale, limited but growing preclinical evidence, human safety data good but not from neurodegenerative disease trials.

Research Gaps and Future Directions

CNS penetration studies: Determine bioavailability to brain tissue

Neurodegeneration trials: Need dedicated trials in AD/PD/CBS/PSP

Optimal delivery: Topical vs. subcutaneous vs. intranasal comparison

Combination protocols: Synergy with other peptides and antioxidants

[BPC-157](/therapeutics/bpc-157) — Often stacked with GHK-Cu
[Copper metabolism](/mechanisms/copper-homeostasis) — Related pathway
[Oxidative stress](/mechanisms/oxidative-stress-neurodegeneration) — Related mechanism

References

[Ahmed et al., Wound Repair Regen. (2016) (2016)](https://doi.org/10.1111/wrr.12444)

[Barcena et al., J. Gerontol. (2018) (2018)](https://doi.org/10.1093/gerona/gly077)

[Campisi et al., Cell Metab. (2019) (2019)](https://doi.org/10.1016/j.cmet.2019.08.020)

[Campisi et al., Aging Cell (2019) (2019)](https://doi.org/10.1111/acel.13033)

[Unknown, Fridovich I., J. Biol. Chem. (1997) (1997)](https://doi.org/10.1074/jbc.272.30.18515)

[Hsu et al., Neural Regen. Res. (2022) (2022)](https://doi.org/10.4103/1673-5374.330458)

[Kadenbach et al., Biochim. Biophys. Acta (2000) (2000)](https://doi.org/10.1016/S0005-2728(00)

[Klis et al., J. Trace Elem. Med. Biol. (2021) (2021)](https://doi.org/10.1016/j.jtemb.2021.126828)

[Luo et al., Antioxidants (2021) (2021)](https://doi.org/10.3390/antiox10050694)

[Lee et al., Aging Cell (2019) (2019)](https://doi.org/10.1111/acel.13033)

[Miller et al., Cytokine (2018) (2018)](https://doi.org/10.1016/j.cyto.2018.03.009)

[Maquart et al., FEBS Lett. (1990) (1990)](https://doi.org/10.1016/0014-5793(90)

[Mochizuki et al., Peptides (2010) (2010)](https://doi.org/10.1016/j.peptides.2010.03.025)

[Pickart et al., J. Inorg. Biochem. (2013) (2013)](https://doi.org/10.1016/j.jinorgbio.2013.01.005)

[Pickart et al., Cosmetics (2016) (2016)](https://doi.org/10.3390/cosmetics3010002)

[Pickart et al., J. Alzheimers Dis. (2015) (2015)](https://doi.org/10.3233/JAD-142511)

[Pickart et al., Int J Cosmet Sci (2015) (2015)](https://doi.org/10.1111/ics.12220)

[Rojkind et al., Connect Tissue Res. (1995) (1995)](https://doi.org/10.3109/03008209509013708)

[Simpson et al., Inflamm. Res. (2020) (2020)](https://doi.org/10.1007/s00011-020-01342-0)

[Sivaraman et al., J. Invest. Dermatol. (2018) (2018)](https://doi.org/10.1016/j.jid.2018.01.034)

[Tainer et al., Curr. Opin. Struct. Biol. (1996) (1996)](https://doi.org/10.1016/S0959-440X(96)

[van Heemst et al., Sci. Rep. (2022) (2022)](https://doi.org/10.1038/s41598-022-13418-4)

[van Heemst et al., Aging (2020) (2020)](https://doi.org/10.18632/aging.103449)

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

[Hippocampal CA3-CA1 circuit rescue via neurogenesis and synaptic preservation](/hypothesis/h-856feb98) — <span style="color:#81c784;font-weight:600">0.73</span> · Target: BDNF
[Vagal Afferent Microbial Signal Modulation](/hypothesis/h-ee1df336) — <span style="color:#81c784;font-weight:600">0.71</span> · Target: GLP1R, BDNF
[Vocal Cord Neuroplasticity Stimulation](/hypothesis/h-e0183502) — <span style="color:#ffd54f;font-weight:600">0.48</span> · Target: CHR2/BDNF

Related Analyses:

[Digital biomarkers and AI-driven early detection of neurodegeneration](/analysis/SDA-2026-04-01-gap-012) 🔄
[What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's disease pathogenesi](/analysis/SDA-2026-04-01-gap-20260401-225155) 🔄
[Circuit-level neural dynamics in neurodegeneration](/analysis/SDA-2026-04-02-26abc5e5f9f2) 🔄

📖 View canonical wiki page →

GHK-Cu — Copper-Binding Tripeptide

GHK-Cu — Copper-Binding Tripeptide

Overview

GHK-Cu — Copper-Binding Tripeptide

Overview

Mechanism of Action

1. Copper Delivery and Enzymatic Cofactor

2. Anti-Inflammatory Effects

3. Tissue Regeneration

4. Anti-Aging and Cellular Senescence

5. Potential Neuroprotective Mechanisms

Evidence in Neurodegenerative Disease

Preclinical Data

Clinical Evidence

Dosing and Administration

Typical Dosing Protocols

Administration Considerations

Safety Profile

Adverse Effects

Contraindications

Drug Interactions

Relevance to CBS/PSP Patient

Potential Benefits

Case For

Case Against

Net Assessment

Research Gaps and Future Directions

Related Pages

References

Related Hypotheses